← Open Payments lookup

JUDE EMELUMBA: Open Payments

NPI 1396185567 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$468 in 24 payments from 8 companies in 2025. Trend: 2023 $539 · 2024 $386 · 2025 $468

Food & beverage: $468
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.4$129
Neurocrine BioSciences, Inc.4$74
E.R. Squibb & Sons, L.L.C.4$72
ABBVIE INC.4$61
Janssen Pharmaceuticals, Inc3$46
Teva Pharmaceuticals USA, Inc.2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Axsome Therapeutics, Inc.1$18

Products named: Qelbree, INGREZZA, COBENFY, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, UZEDY, AUSTEDO XR.

Industry payments across NJ — which companies pay providers there.